Literature DB >> 24690529

α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.

Katharine K Duncan1, Katerina Otrubova1, Dale L Boger2.   

Abstract

A series of α-ketooxazoles containing heteroatoms embedded within conformational constraints in the C2 acyl side chain of 2 (OL-135) were synthesized and evaluated as inhibitors of fatty acid amide hydrolase (FAAH). The studies reveal that the installation of a heteroatom (O) in the conformational constraint is achievable, although the potency of these novel derivatives is reduced slightly relative to 2 and the analogous 1,2,3,4-tetrahydronaphthalene series. Interestingly, both enantiomers (R and S) of the candidate inhibitors bearing a chiral center adjacent to the electrophilic carbonyl were found to effectively inhibit FAAH.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fatty acid amide hydrolase; α-Ketoheterocycles

Mesh:

Substances:

Year:  2014        PMID: 24690529      PMCID: PMC4029506          DOI: 10.1016/j.bmc.2014.03.013

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  84 in total

1.  Activity-based protein profiling: the serine hydrolases.

Authors:  Y Liu; M P Patricelli; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 2.  Mechanism-based profiling of enzyme families.

Authors:  Michael J Evans; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2006-08       Impact factor: 60.622

3.  Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist.

Authors:  S R Fernando; R G Pertwee
Journal:  Br J Pharmacol       Date:  1997-08       Impact factor: 8.739

4.  Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.

Authors:  Marvin J Meyers; Scott A Long; Matthew J Pelc; Jane L Wang; Scott J Bowen; Barbara A Schweitzer; Mark V Wilcox; Joseph McDonald; Sarah E Smith; Susan Foltin; Jeanne Rumsey; Young-Sun Yang; Mark C Walker; Satwik Kamtekar; David Beidler; Atli Thorarensen
Journal:  Bioorg Med Chem Lett       Date:  2011-08-19       Impact factor: 2.823

5.  Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties.

Authors:  M P Patricelli; M A Lovato; B F Cravatt
Journal:  Biochemistry       Date:  1999-08-03       Impact factor: 3.162

6.  Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase.

Authors:  D G Deutsch; R Omeir; G Arreaza; D Salehani; G D Prestwich; Z Huang; A Howlett
Journal:  Biochem Pharmacol       Date:  1997-02-07       Impact factor: 5.858

7.  The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.

Authors:  Lamont Booker; Steven G Kinsey; Rehab A Abdullah; Jacqueline L Blankman; Jonathan Z Long; Cyrine Ezzili; Dale L Boger; Benjamin F Cravatt; Aron H Lichtman
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

8.  Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues.

Authors:  Katerina Otrubova; Monica Brown; Michael S McCormick; Gye W Han; Scott T O'Neal; Benjamin F Cravatt; Raymond C Stevens; Aron H Lichtman; Dale L Boger
Journal:  J Am Chem Soc       Date:  2013-04-12       Impact factor: 15.419

9.  Functional disassociation of the central and peripheral fatty acid amide signaling systems.

Authors:  Benjamin F Cravatt; Alan Saghatelian; Edward G Hawkins; Angela B Clement; Michael H Bracey; Aron H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

10.  Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.

Authors:  Christophe Hardouin; Michael J Kelso; F Anthony Romero; Thomas J Rayl; Donmienne Leung; Inkyu Hwang; Benjamin F Cravatt; Dale L Boger
Journal:  J Med Chem       Date:  2007-06-09       Impact factor: 7.446

View more
  3 in total

1.  Preclinical Characterization of the FAAH Inhibitor JNJ-42165279.

Authors:  John M Keith; William M Jones; Mark Tichenor; Jing Liu; Mark Seierstad; James A Palmer; Michael Webb; Mark Karbarz; Brian P Scott; Sandy J Wilson; Lin Luo; Michelle L Wennerholm; Leon Chang; Michele Rizzolio; Raymond Rynberg; Sandra R Chaplan; J Guy Breitenbucher
Journal:  ACS Med Chem Lett       Date:  2015-11-02       Impact factor: 4.345

2.  Discovery libraries targeting the major enzyme classes: the serine hydrolases.

Authors:  Katerina Otrubova; Venkat Srinivasan; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2014-06-27       Impact factor: 2.823

3.  The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry-Biology Interface.

Authors:  Dale L Boger
Journal:  J Org Chem       Date:  2017-10-13       Impact factor: 4.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.